Jonathan Alicea

The findings also showed that large bedded hospitals trended towards higher clostridium difficile infection incidence and mortality rates.

A new study demonstrates that vedolizumab is associated with real-world corticosteroid-free response and remission in patients with ulcerative colitis and Crohn’s disease.

Brooks Cash, MD, discusses the importance of bowel preparation and surveillance in patients with diabetes.

A poster presented at ACG provides an updated analysis of clostridium difficile infection in the tofacitinib UC clinical program.

New data presented at ACG 2020 shows NER1006 bowel preparation to be safe and efficacious in patients with diabetes preparing for their colonoscopy.

An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.

New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.

A new study presented at ACG shows vedolizumab to be superior to adalimumab in maintaining early disease control in patients with moderate-to-severe ulcerative colitis.

Patients with chronic pancreatitis can exhibit dependence on chronic opioid therapy prior to receiving total pancreatectomy with islet autotransplantation.

Isolation as a result of suspected C. Diff can take a significant financial toll on the healthcare system, thus it is necessary to determine appropriate factors that can predict CDI.

The double-blind trial reported on long-term cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.

Compared with prophylaxis anticoagulation, full dose anticoagulation provided a greater survival benefit to those in a predominantly black population.

In the inaugural episode of Derm Discussions, Seemal Desai, MD, joins Brad Glick, DO, for an update on dermatologic burdens in people of color.

A majority of the patients included in the analysis (93%) indicated they had uncontrolled asthma.

Brad Glick gives an overview of new and exciting trends in the field of dermatology.

According to recommendations, electronic media should actively engage in efforts to address the prevention and management of sickle cell disease.

The Full Field Peripheral Blood Smear application addresses shortcomings of current digital solutions.

Brad Glick, DO, FAAD, previews a few of the topics that will be discussed on Derm Discussions, HCPLive's new expert-led skin health podcast series.

A common theme among clinical staff focus groups was the pervasiveness of systemic and social barriers to addressing basic needs in children with sickle cell disease.

The host of HCPLive's new derm podcast series discusses what to expect as well as the importance of multimedia medical news.

These findings suggest a potential in developing preventative vaccines against C. difficile infection.

Multi-center, sickle cell studies may face a host of barriers and challenges in achieving target sample sizes.

Venetoclax in combination with azacitidine was shown to prolong survival and increase chance of remission.

The COVID-19 pandemic has placed burdens on access to in-person health services; therefore, safe and practical allergy management / prevention processes are necessary.

New data shows that clinical isolates of C. difficile are variably affected by manuka honey in terms of growth inhibition and bactericidal activity.

The quadrivalent, virus-like particle influenza vaccine has potential to offer substantial protection in adults.

A higher proportion of risankizumab users achieved improved measures for symptoms, quality of life, and mental health versus comparators.

The first-in-class drug in severe asthma significantly reduced the exacerbation rate by 35% compared with placebo.

The drug has potential to be best-in-class treatment option for children aged 6-11 years with uncontrolled moderate-to-severe asthma.

An expert offers 5 tips to physicians and patients on best practices for managing symptoms related to allergic asthma.